<DOC>
	<DOC>NCT03092921</DOC>
	<brief_summary>This investigation is designed to evaluate the performance as well as the patients overall acceptance of the seal.</brief_summary>
	<brief_title>The Evaluation of a Mask Seal for the Treatment of Obstructive Sleep Apnea (OSA)</brief_title>
	<detailed_description>A minimum of 15 OSA participants who currently use a Full face mask will be recruited for the trial. Participant will be on the trial for 1 week- The participant will use the trial seal in-home for 1 week.</detailed_description>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea, Obstructive</mesh_term>
	<criteria>Adult (18+ years of age) Able to give consent Apnea hypopnea Index (AHI)â‰¥ 5 on diagnostic night Prescribed PAP for OSA Existing oronasal mask user Inability to give consent Patients who are in a coma or a decreased level of consciousness Anatomical or physiological conditions making automatic positive airway pressure (APAP) therapy inappropriate (e.g. unconsolidated facial structure) Commercial drivers who are investigated by New Zealand Transport Agency Current diagnosis of carbon dioxide (CO2) retention Pregnant or may think they are pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>